Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin Open Label Extension in Diabetic Peripheral Neuropathy
NCT00159731Phase 4Completed
- Sponsor
- Viatris
- Start
- Jan 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of pregabalin in diabetic peripheral neuropathy (DPN), sponsored by Viatris. Primary endpoint: Adverse events. Started Jan 2005; status: completed.
02
Drugs
pregabalin
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT00159731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00159731.